Takeda Pharmaceutical Co., Ltd.


  • 1m
  • 3m
  • 6m
  • 1y
  • 2y
  • 5y
Mar 24, 2017
Prev close: 5,262
Mar 24, 2017
Market cap:
Market cap(USD):
Shares: 790.41M

Currency in JPY

Company profile

Market(Ticker): TKS(4502)
Health Technology
Pharmaceuticals: Major
Full time employees: 31,168

Business summary

Takeda Pharmaceutical Co., Ltd. is a research-based global pharmaceutical company that engages in the manufacture, sale, import, export, and marketing of pharmaceutical drugs. It operates through the following segments: Ethical Drug, Consumer Healthcare, and Others. The Ethical Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Others segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

In the news

Financial highlights

Mar 2016

  • Local currency
  • US Dollar
Revenue 1,807.37B
Gross profit 1,153.28B
Operating income 149,862M
Income before tax 120,542M
Net income 80,166M
EBITDA 332,041M
Diluted EPS 101.71
Dividends per share 180
Total assets 3,824.08B
Total liabilities 1,812.88B
Total equity 1,948.69B
Operating cash flow 26,552M

Currency in JPY

Revenue 15,050.91M
Gross profit 9,603.99M
Operating income 1,247.97M
Income before tax 1,003.81M
Net income 667.58M
EBITDA 2,765.06M
Diluted EPS 0.84
Dividends per share 1.49
Total assets 34,023.62M
Total liabilities 16,129.56M
Total equity 17,337.88M
Operating cash flow 221.11M

Currency in USD

Valuation measures

Mar 2016

PER 50.22
ROA 1.97%
ROE 3.92%
Operating margin 8.29%
Profit margin 4.43%

Key executive

  • President, CEO & Representative Director: Christophe Weber
  • Chief Financial & Corporate Officer: James Kehoe
  • Director, Chief Medical & Scientific Officer: Andrew S. Plump
  • Manager-Research & Development: Shinji Ninomiya
  • Executive Officer & Global General Counsel: Yoshihiro Nakagawa

Share holders

  • Nippon Life Insurance Co.(6.4%)
  • Capital Research & Management Co. (Global Investors)(2.9%)
  • Nomura Asset Management Co., Ltd.(2.5%)
  • Takeda Science Foundation(2.2%)
  • The Vanguard Group, Inc.(2.0%)
  • Wellington Management Co. LLP(1.4%)
  • BlackRock Fund Advisors(1.4%)
  • Capital Research & Management Co. (World Investors)(1.1%)
  • Nikko Asset Management Co., Ltd.(1.1%)
  • Daiwa Asset Management Co. Ltd.(1.1%)


  • Website: http://www.takeda.co.jp
  • Address: 4-1-1 Dosho-machi, Chuo-Ku, Osaka, 540-8645, Japan
  • Phone: +81.6.6204.2111

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.